Compagnie Lombard Odier SCmA’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-700
| Closed | -$6K | – | 561 |
|
|
2020
Q2 | $6K | Hold |
700
| – | – | ﹤0.01% | 485 |
|
|
2020
Q1 | $3K | Hold |
700
| – | – | ﹤0.01% | 467 |
|
|
2019
Q4 | $3K | Hold |
700
| – | – | ﹤0.01% | 482 |
|
|
2019
Q3 | $2K | Hold |
700
| – | – | ﹤0.01% | 497 |
|
|
2019
Q2 | $3K | Hold |
700
| – | – | ﹤0.01% | 484 |
|
|
2019
Q1 | $3K | Hold |
700
| – | – | ﹤0.01% | 524 |
|
|
2018
Q4 | $3K | Hold |
700
| – | – | ﹤0.01% | 514 |
|
|
2018
Q3 | $5K | Hold |
700
| – | – | ﹤0.01% | 519 |
|
|
2018
Q2 | $5K | Hold |
700
| – | – | ﹤0.01% | 556 |
|
|
2018
Q1 | $5K | Sell |
700
-700
| -50% | -$5K | ﹤0.01% | 563 |
|
|
2017
Q4 | $6K | Buy |
1,400
+700
| +100% | +$3K | ﹤0.01% | 604 |
|
|
2017
Q3 | $4K | Hold |
700
| – | – | ﹤0.01% | 651 |
|
|
2017
Q2 | $6K | Hold |
700
| – | – | ﹤0.01% | 660 |
|
|
2017
Q1 | $6K | Sell |
700
-1,500
| -68% | -$12.9K | ﹤0.01% | 678 |
|
|
2016
Q4 | $19K | Sell |
2,200
-500
| -19% | -$4.32K | ﹤0.01% | 704 |
|
|
2016
Q3 | $19K | Buy |
2,700
+2,000
| +286% | +$14.1K | ﹤0.01% | 790 |
|
|
2016
Q2 | $3K | Hold |
700
| – | – | ﹤0.01% | 870 |
|
|
2016
Q1 | $7K | Hold |
700
| – | – | ﹤0.01% | 907 |
|
|
2015
Q4 | $7K | Buy |
+700
| New | +$7K | ﹤0.01% | 870 |
|